文献速递神经MR

基于影像的成人胶质瘤分层可预测生存并与2021年WHO分类相关

Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification.
PubMed 文献 · Neuroradiology · 2022-07-25

本研究在回顾性数据集中建立基于影像的成人胶质瘤分层(IBGS),用T2-FLAIR不匹配征、中央坏死伴周边强化、弥散受限和连续皮层征将肿瘤分为I、II、III型;在两个数据集中分层对生存的预测有统计学意义(年龄校正Cox回归,AUC>0.5,k>0.6,p<0.001),且各型对相应2021年WHO基因型有较好特异度。

要点

  • IBGS分型依据四个MRI征象:T2-FLAIR不匹配征、中央坏死伴周边强化、弥散受限、连续皮层征。
  • IBGS I型对应IDH突变伴1p/19q共缺失少突胶质瘤,训练集特异度97%、验证集85%。
  • IBGS II型对应IDH突变伴1p/19q非共缺失星形细胞瘤,训练集特异度80%、验证集85.9%。

核心结论

  • 成人弥漫性胶质瘤的影像分层可预测患者生存,并与2021年WHO胶质瘤分类相关性良好。

研究设计与样本

  • 回顾性研究,训练集来自TCIA(n=275)、独立验证集(n=200),纳入有术前MRI(T2、FLAIR、T1、T1增强、DWI)及生存信息的成人原发性胶质瘤患者;三名作者共识制定IBGS流程图,两独立放射科医师团队在不知基因、组织学和生存信息下手工阅读MRI分型;采用年龄校正Cox回归分析生存,交叉表分析各IBGS型与2021年WHO基因型的敏感度和特异度。

关键影像表现/征象

  • 诊断特征包括T2-FLAIR不匹配征、中央坏死伴周边强化、弥散受限和连续皮层征。
  • 以罗马数字I、II、III表示IBGS类型。

诊断标准与关键数值

  • IBGS I型识别IDH突变伴1p/19q共缺失少突胶质瘤的特异度:训练集97%、验证集85%(p<0.01)。
  • IBGS II型识别IDH突变伴1p/19q非共缺失星形细胞瘤的特异度:训练集80%、验证集85.9%(p<0.01)。
  • IBGS III型识别IDH野生型胶质母细胞瘤的特异度:训练集76.5%、验证集87.3%(p<0.01)。
  • 两个数据集中IBGS预测生存均有统计学意义(年龄校正Cox回归,AUC>0.5,k>0.6,p<0.001)。

临床应用与阅片要点

  • 阅片时可依据T2-FLAIR不匹配征、中央坏死伴周边强化、弥散受限和连续皮层征按IBGS流程图将成人胶质瘤分为I、II、III型。
  • IBGS分型与2021年WHO基因型相关,各型对相应基因型有较高特异度,可辅助影像报告分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Because of the lack of global accessibility, delay, and cost-effectiveness of genetic testing, there is a clinical need for an imaging-based stratification of gliomas that can prognosticate survival and correlate with the 2021-WHO classification.

METHODS: In this retrospective study, adult primary glioma patients with pre-surgery/pre-treatment MRI brain images having T2, FLAIR, T1, T1 post-contrast, DWI sequences, and survival information were included in TCIA training-dataset (n = 275) and independent validation-dataset (n = 200). A flowchart for imaging-based stratification of adult gliomas(IBGS) was created in consensus by three authors to encompass all adult glioma types. Diagnostic features used were T2-FLAIR mismatch sign, central necrosis with peripheral enhancement, diffusion restriction, and continuous cortex sign. Roman numerals (I, II, and III) denote IBGS types. Two independent teams of three and two radiologists, blinded to genetic, histology, and survival information, manually read MRI into three types based on the flowchart. Overall survival-analysis was done using age-adjusted Cox-regression analysis, which provided both hazard-ratio (HR) and area-under-curve (AUC) for each stratification system(IBGS and 2021-WHO). The sensitivity and specificity of each IBSG type were analyzed with cross-table to identify the corresponding 2021-WHO genotype.

RESULTS: Imaging-based stratification was statistically significant in predicting survival in both datasets with good inter-observer agreement (age-adjusted Cox-regression, AUC > 0.5, k > 0.6, p < 0.001). IBGS type-I, type-II, and type-III gliomas had good specificity in identifying IDHmut 1p19q-codel oligodendroglioma (training - 97%, validation - 85%); IDHmut 1p19q non-codel astrocytoma (training - 80%, validation - 85.9%); and IDHwt glioblastoma (training - 76.5%, validation- 87.3%) respectively (p-value < 0.01).

CONCLUSIONS: Imaging-based stratification of adult diffuse gliomas predicted patient survival and correlated well with 2021-WHO glioma classification.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Kamble, Agrawal, Koundal, et al. Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification. Neuroradiology. 2022. PMID: 35876874. doi:10.1007/s00234-022-03015-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。